Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldafermin in Chronic Diarrhea Due to Bile Acid Malabsorption
NCT05130047Phase 2Completed
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of aldafermin in bile acid malabsorption (BAM). Started Dec 2021; status: completed.
02
Drugs
aldafermin
03
Conditions
bile acid malabsorption (BAM)
Beyond the preview
Go deeper on NCT05130047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05130047.